Structures by: Tabuchi Y.
Total: 17
C26H40O2S2Si2
C26H40O2S2Si2
Organic & biomolecular chemistry (2015) 13, 21 5964-5971
a=11.205(3)Å b=11.346(3)Å c=13.093(4)Å
α=108.312(3)° β=90.218(3)° γ=112.482(3)°
C36H27OP
C36H27OP
Journal of the Chemical Society, Perkin Transactions 1 (2002) 18 2090
a=21.492(1)Å b=8.0545(4)Å c=15.4024(9)Å
α=90.0(5)° β=96.1(8)° γ=90.0(6)°
4-(<i>n</i>-Pentyloxy)benzoic acid--(<i>E</i>)-1,2-bis(pyridin-4-yl)ethene (2/1)
2(C12H16O3),C12H10N2
Acta Crystallographica Section E (2016) 72, 12 1771-1775
a=7.406(4)Å b=9.042(4)Å c=11.719(5)Å
α=80.420(17)° β=81.03(2)° γ=87.66(3)°
4-(<i>n</i>-Hexyloxy)benzoic acid--(<i>E</i>)-1,2-bis(pyridin-4-yl)ethene
2(C13H18O3),C12H10N2
Acta Crystallographica Section E (2016) 72, 12 1771-1775
a=9.107(3)Å b=12.020(5)Å c=16.672(6)Å
α=81.584(16)° β=88.416(15)° γ=67.905(15)°
4-Methoxybenzoic acid--(<i>E</i>)-1,2-di(pyridin-4-yl)ethene (2/1)
2(C8H8O3),C12H10N2
Acta Crystallographica Section E (2016) 72, 11 1666-1671
a=11.259(4)Å b=7.2693(17)Å c=14.758(4)Å
α=90.0000° β=105.706(15)° γ=90.0000°
4-Ethoxybenzoic acid--(<i>E</i>)-1,2-di(pyridin-4-yl)ethene (2/1)
2(C9H10O3),C12H10N2
Acta Crystallographica Section E (2016) 72, 11 1666-1671
a=10.873(3)Å b=11.197(4)Å c=12.921(4)Å
α=82.399(13)° β=66.241(10)° γ=62.207(11)°
4-<i>n</i>-Propoxybenzoic acid--(<i>E</i>)-1,2-di(pyridin-4-yl)ethene (2/1)
2(C10H12O3),C12H10N2
Acta Crystallographica Section E (2016) 72, 11 1666-1671
a=11.1192(18)Å b=10.8289(13)Å c=23.020(3)Å
α=90.0000° β=93.517(8)° γ=90.0000°
4-<i>n</i>-Propoxybenzoic acid--4,4'-bipyridyl (2/1)
2(C10H12O3),C10H8N2
Acta Crystallographica Section E (2015) 71, 11 1290-1295
a=10.7592(4)Å b=10.8838(3)Å c=11.6462(4)Å
α=86.6411(11)° β=89.2313(13)° γ=73.8867(12)°
4-Ethoxybenzoic acid--4,4'-bipyridyl (2/1)
2(C9H10O3),C10H8N2
Acta Crystallographica Section E (2015) 71, 11 1290-1295
a=9.1090(2)Å b=20.9348(5)Å c=12.8738(4)Å
α=90.0000° β=102.9429(10)° γ=90.0000°
4-<i>n</i>-Butoxybenzoic acid--4,4'-bipyridyl (2/1)
2(C11H14O3),C10H8N2
Acta Crystallographica Section E (2015) 71, 11 1290-1295
a=7.6645(10)Å b=8.5087(13)Å c=22.606(3)Å
α=80.498(3)° β=86.486(3)° γ=80.082(3)°
4-Ethoxybenzoic acid--1,2-bis(pyridin-4-yl)ethane (2/1)
2(C9H10O3),C12H12N2
Acta Crystallographica Section E (2015) 71, 11 1340-1344
a=6.967(3)Å b=9.163(4)Å c=10.813(6)Å
α=75.41(2)° β=74.97(2)° γ=77.801(19)°
4-<i>n</i>-Propoxybenzoic acid--1,2-bis(pyridin-4-yl)ethane (2/1)
2(C10H12O3),C12H12N2
Acta Crystallographica Section E (2015) 71, 11 1340-1344
a=9.121(3)Å b=12.552(5)Å c=13.306(6)Å
α=71.328(16)° β=75.076(18)° γ=89.817(16)°
4-<i>n</i>-Butoxybenzoic acid--1,2-bis(pyridin-4-yl)ethane (2/1)
2(C11H14O3),C12H12N2
Acta Crystallographica Section E (2015) 71, 11 1340-1344
a=7.702(2)Å b=10.726(4)Å c=19.010(7)Å
α=83.861(17)° β=78.794(16)° γ=73.612(15)°
2-Carboxypyridinium hydrogen chloranilate
C6H6NO2,C6HCl2O4
Acta Crystallographica Section E (2005) 61, 12 o4215-o4217
a=10.7715(10)Å b=5.4301(5)Å c=12.9139(12)Å
α=90° β=119.580(7)° γ=90°
Alpinumisoflavone
C20H16O5
Acta Crystallographica Section E (2008) 64, 4 o713
a=13.8333(3)Å b=5.92699(17)Å c=19.8352(4)Å
α=90.0000° β=99.6806(7)° γ=90.0000°
4-Carboxypyridinium hydrogen chloranilate monohydrate
C6H6NO2,C6HCl2O4,H2O
Acta Crystallographica Section E (2006) 62, 10 o4420-o4421
a=12.9472(3)Å b=7.7206(2)Å c=13.8128(3)Å
α=90.0000° β=93.4766(11)° γ=90.0000°
4-<i>n</i>-Butoxybenzoic acid--(<i>E</i>)-1,2-di(pyridin-4-yl)ethene (2/1)
2(C11H14O3),C12H10N2
Acta Crystallographica Section E (2016) 72, 11 1666-1671
a=7.103(4)Å b=9.060(5)Å c=11.627(7)Å
α=82.29(2)° β=78.54(3)° γ=86.79(3)°